Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology

•A new diagnostic tool to distinguish vaccinated from infected immune response for HAV.•Clinical validation of HAV multiplex serology.•High sensitivity, specificity and accuracy to measure HAV infection and vaccination.•Using Luminex® technology to facilitate sero-epidemiological studies. Worldwide...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine Vol. 35; no. 43; pp. 5883 - 5889
Main Authors: Bohm, Katrin, Filomena, Angela, Schneiderhan-Marra, Nicole, Krause, Gérard, Sievers, Claudia
Format: Journal Article
Language:English
Published: Netherlands Elsevier Ltd 13.10.2017
Elsevier Limited
Subjects:
ISSN:0264-410X, 1873-2518, 1873-2518
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first